Fernanda Piorino

Fernanda Piorino

Auto-generated profile, based on publicly available information

Fernanda Piorino

National Institute of Standard and Technology

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2022 in Current Opinion in Biotechnology
Verified
Journal Article
Closed access
FPFernanda Piorino
Fernanda Piorino
APAlexandra T Patterson
Alexandra T Patterson
MSMark Styczynski
Mark Styczynski

3 September 2021 in ACS Synthetic Biology
Verified
Journal Article
Open access
AMApril M. Miguez
April M. Miguez
YZYan Zhang
Yan Zhang
FPFernanda Piorino
Fernanda Piorino
MSMark Styczynski
Mark Styczynski
The field of metabolic engineering has yielded remarkable accomplishments in using cells to produce valuable molecules, and cell-free expression (CFE) systems have the potential to push the field even further. However, CFE systems still face some outstanding challenges, including endogenous metabolic activity that is poorly understood yet has a significant impact on CFE productivity. Here, we use metabolomics to characterize the temporal metabolic changes in CFE systems and their constituent components, including significant metabolic activity in central carbon and amino acid metabolism. We find that while changing the reaction starting state via lysate preincubation impacts protein production, it has a comparatively small impact on metabolic state. We also demonstrate that changes to lysate preparation have a larger effect on protein yield and temporal metabolic profiles, though general metabolic trends are conserved. Finally, while we improve protein production through targeted supplementation of metabolic enzymes, we show that the endogenous metabolic activity is fairly resilient to these enzymatic perturbations. Overall, this work highlights the robust nature of CFE reaction metabolism as well as the importance of understanding the complex interdependence of metabolites and proteins in CFE systems to guide optimization efforts.

17 July 2023 in ACS Synthetic Biology
Verified
Journal Article
Open access
FPFernanda Piorino
Fernanda Piorino
SJShelbe Johnson
Shelbe Johnson
MSMark Styczynski
Mark Styczynski
Hyperhomocysteinemia─a condition characterized by elevated levels of homocysteine in the blood─is associated with multiple health conditions including folate deficiency and birth defects, but there are no convenient, low-cost methods to measure homocysteine in plasma. A cell-free biosensor that harnesses the native homocysteine sensing machinery of Escherichia coli bacteria could satisfy the need for a detection platform with these characteristics. Here, we describe our efforts to engineer a cell-free biosensor for point-of-care, low-cost assessment of homocysteine status. This biosensor can detect physiologically relevant concentrations of homocysteine in plasma with a colorimetric output visible to the naked eye in under 1.5 h, making it a fast, convenient tool for point-of-use diagnosis and monitoring of hyperhomocysteinemia and related health conditions.

2 March 2022 in Current Opinion in Biotechnology
Verified
Journal Article
Closed access
HSHarini Sridharan
Harini Sridharan
FPFernanda Piorino
Fernanda Piorino
MSMark Styczynski
Mark Styczynski

16 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
SISvetlana P. Ikonomova
Svetlana P. Ikonomova
BWBruce J. Wittmann
Bruce J. Wittmann
FPFernanda Piorino
Fernanda Piorino
DRDavid J. Ross
David J. Ross
SSSamuel W. Schaffter
Samuel W. Schaffter
GTGeoffrey J. Taghon
Geoffrey J. Taghon
Advances in machine learning are providing leaps forward for beneficial applications of protein engineering, while also raising concerns about biosecurity. Recently, Wittmann et al. described an in silico pipeline of generative AI tools to reformulate sequences of concern (SOCs) as synthetic homologs that may evade detection by biosecurity screening software (BSS) used by nucleic acid synthesis providers. Experimental testing of synthetic homologs is required to ascertain the true severity of this vulnerability. We present a generalizable framework to assess biosecurity risk consisting of testing, evaluation, validation, and verification (TEVV) of AI-assisted protein design (AIPD). We determine that common AIPD models in use at the time this study was initiated (early 2024) are not yet powerful enough to reliably rewrite the sequence of a given protein, while both maintaining activity and evading detection by BSS.

27 September 2023 in ACS Synthetic Biology
Verified
Journal Article
Open access
FPFernanda Piorino
Fernanda Piorino
APAlexandra T. Patterson
Alexandra T. Patterson
YHYue Han
Yue Han
MSMark Styczynski
Mark Styczynski
Although cell-free protein expression has been widely used for the synthesis of single proteins, cell-free synthetic biology has rapidly expanded to new, more complex applications. One such application is the prototyping or implementation of complex genetic networks involving the expression of multiple proteins at precise ratios, often from different plasmids. However, expression of multiple proteins from multiple plasmids may inadvertently result in unexpected, off-target changes to the levels of the proteins being expressed, a phenomenon termed plasmid crosstalk. Here, we show that the effects of plasmid crosstalk-even at the qualitative level of increases vs decreases in protein expression-depend on the concentration of plasmids in the reaction and the type of transcriptional machinery involved in the expression. This crosstalk can have a significant impact on genetic circuitry function and even interpretation of simple experimental results and thus should be taken into consideration during the development of cell-free applications.